Skip to main content
. 2023 Dec 22;13(1):13. doi: 10.3390/pathogens13010013

Table 1.

Seroreactivity to four Rickettsia species in humans, dogs, and terrestrial small mammals from Parque Nacional das Emas (PNE), state of Goiás, from February 2020 to September 2021.

Humans, Dogs, and Terrestrial Small Mammal
Species (Tested Specimens)
Number of Animals Reactive to Each Rickettsia spp./% Seroreactivity (Endpoint Titers) No. Individuals with PAIHR a
R. rickettsii R. parkeri R. bellii R. ammblyommatis
Humans (17) 0/0 0/0 3/17.6 (128–256) 1/5.9 (64) 3 R. bellii
Dogs (41) 3/7.3 (64) 0/0 7/17.1 (64–512) 2/4.9 (64) 4 R. bellii
Calomys tener (1) 0/0 0/0 0/0 0/0
Cerradomys maracajuensis (1) 0/0 0/0 0/0 0/0
Cerradomys scotti (1) 0/0 0/0 0/0 0/0
Clyomys laticeps (1) 0/0 0/0 0/0 0/0
Didelphis albiventris (1) 0/0 0/0 0/0 1/100 (64)
Gracilinanus agilis (2) 1/50 (128) 0/0 0/0 0/0 1 R. rickettsii
Necromys lasiurus (6) 0/0 0/0 0/0 0/0
Nectomys squamipes (4) 0/0 1/25 (128) 0/0 0/0 1 R. parkeri
Oecomys cleberi (1) 0/0 0/0 0/0 0/0
Oecomys roberti (1) 0/0 0/0 0/0 0/0
Oligoryzomys cf. mattogrossae (6) 0/0 0/0 0/0 0/0
Oxymycterus delator (1) 0/0 1/100 (128) 0/0 0/0 1 R. parkeri
TOTAL (84) 4/4.8 2/2.4 10/12 4/4.8

a PAIHR, possible antigen involved in a homologous reaction. A homologous reaction was determined when the endpoint titer to a Rickettsia species was at least four-fold higher than the endpoint titers observed for the other three Rickettsia species. In this case, the Rickettsia species (or a very closely related genotype) involved in the highest endpoint titer was considered the PAIHR.